These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33405030)

  • 21. An Era of CRISPR/ Cas9 Mediated Plant Genome Editing.
    Khurshid H; Jan SA; Shinwari ZK; Jamal M; Shah SH
    Curr Issues Mol Biol; 2018; 26():47-54. PubMed ID: 28879855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
    Hiranniramol K; Chen Y; Wang X
    Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-expression of Cas9 and single-guided RNAs in
    Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y
    Commun Biol; 2019; 2():161. PubMed ID: 31069270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient Editing of the Nuclear
    Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dead Cas Systems: Types, Principles, and Applications.
    Brezgin S; Kostyusheva A; Kostyushev D; Chulanov V
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9.
    Meijers AS; Troost R; Ummels R; Maaskant J; Speer A; Nejentsev S; Bitter W; Kuijl CP
    Tuberculosis (Edinb); 2020 Sep; 124():101983. PubMed ID: 32829077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9 genome engineering of primary CD4
    Hultquist JF; Hiatt J; Schumann K; McGregor MJ; Roth TL; Haas P; Doudna JA; Marson A; Krogan NJ
    Nat Protoc; 2019 Jan; 14(1):1-27. PubMed ID: 30559373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
    Shou J; Li J; Liu Y; Wu Q
    Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-mediated genome editing efficiently creates specific mutations at multiple loci using one sgRNA in Brassica napus.
    Yang H; Wu JJ; Tang T; Liu KD; Dai C
    Sci Rep; 2017 Aug; 7(1):7489. PubMed ID: 28790350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Target-Specific Precision of CRISPR-Mediated Genome Editing.
    Chakrabarti AM; Henser-Brownhill T; Monserrat J; Poetsch AR; Luscombe NM; Scaffidi P
    Mol Cell; 2019 Feb; 73(4):699-713.e6. PubMed ID: 30554945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
    Cullot G; Boutin J; Toutain J; Prat F; Pennamen P; Rooryck C; Teichmann M; Rousseau E; Lamrissi-Garcia I; Guyonnet-Duperat V; Bibeyran A; Lalanne M; Prouzet-Mauléon V; Turcq B; Ged C; Blouin JM; Richard E; Dabernat S; Moreau-Gaudry F; Bedel A
    Nat Commun; 2019 Mar; 10(1):1136. PubMed ID: 30850590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type II anti-CRISPR proteins as a new tool for synthetic biology.
    Zhang Y; Marchisio MA
    RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.